ReviewCardiovascular diabetology2019

Sotagliflozin, the first dual SGLT inhibitor: current outlook and perspectives.

Chiara Maria Assunta Cefalo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.